Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 2:31 pm Sale | 2022-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | FIRST MANHATTAN CO. LLC. | 243,718 1.170% | -865,118 (-78.02%) | Filing History |
| 2023-02-14 2:30 pm Sale | 2022-12-31 | 13G | AgroFresh Solutions, Inc. AGFS | FIRST MANHATTAN CO. LLC. | 2,040,653 3.850% | -690,592 (-25.28%) | Filing History |
| 2022-02-14 6:18 pm Purchase | 2021-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | FIRST MANHATTAN CO. LLC. | 1,108,836 5.460% | 343,268 (+44.84%) | Filing History |
| 2022-02-14 6:16 pm Sale | 2021-12-31 | 13G | Safeguard Scientifics, Inc. SFE | FIRST MANHATTAN CO. LLC. | 1,088,668 6.600% | -27,439 (-2.46%) | Filing History |
| 2022-02-14 6:16 pm Purchase | 2021-12-31 | 13G | AgroFresh Solutions, Inc. AGFS | FIRST MANHATTAN CO. LLC. | 2,731,245 5.220% | 376,832 (+16.01%) | Filing History |
| 2022-02-14 6:16 pm Purchase | 2021-12-31 | 13G | Evolus, Inc. EOLS | FIRST MANHATTAN CO. LLC. | 3,334,916 6.000% | 3,334,916 (New Position) | Filing History |
| 2022-02-14 6:16 pm Sale | 2021-12-31 | 13G | Cara Therapeutics, Inc. CARA | FIRST MANHATTAN CO. LLC. | 0 0.000% | -89,244 (Position Closed) | Filing History |
| 2021-02-16 2:41 pm Sale | 2020-12-31 | 13G | AgroFresh Solutions, Inc. AGFS | FIRST MANHATTAN CO. LLC. | 2,354,413 4.440% | -711,024 (-23.19%) | Filing History |
| 2021-02-16 2:41 pm Purchase | 2020-12-31 | 13G | Cara Therapeutics, Inc. CARA | FIRST MANHATTAN CO. LLC. | 89,244 6.450% | 89,244 (New Position) | Filing History |
| 2021-02-16 2:41 pm Purchase | 2020-12-31 | 13G | MENLO THERAPEUTICS INC MNLO | FIRST MANHATTAN CO. LLC. | 9,106 0.010% | 9,106 (New Position) | Filing History |
| 2021-02-16 2:41 pm Purchase | 2020-12-31 | 13G | The New Home Company Inc. NWHM | FIRST MANHATTAN CO. LLC. | 1,071,551 5.880% | 32,160 (+3.09%) | Filing History |
| 2021-02-16 2:41 pm Purchase | 2020-12-31 | 13G | Otonomy, Inc. OTIC | FIRST MANHATTAN CO. LLC. | 1,949,963 4.040% | 377,230 (+23.99%) | Filing History |
| 2021-02-16 2:41 pm Sale | 2020-12-31 | 13G | Safeguard Scientifics, Inc. SFE | FIRST MANHATTAN CO. LLC. | 1,116,107 5.340% | -49,053 (-4.21%) | Filing History |
| 2021-02-16 2:41 pm Sale | 2020-12-31 | 13G | MENLO THERAPEUTICS INC MNLO | FIRST MANHATTAN CO. LLC. | 21,319 0.010% | -2,146,694 (-99.02%) | Filing History |